-
-
-
-
-
-
-
Active Biotech Year-end report January – December 2020
-
-
-
-
-
-
-
Active Biotech and Ipsen announce their decision to discontinue the development of tasquinimod in prostate cancer
-
1,198,700 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

